US 10420851
Stabilized radiolabeled anti-CD45 immunoglobulin compositions
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 10420851 (Stabilized radiolabeled anti-CD45 immunoglobulin compositions) held by Actinium Phamaceuticals, Inc. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Actinium Phamaceuticals, Inc.
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K35/28, A61K39/39591